Cosmeceuticals or Not? The Industry View: Europe
Peter Elsner, Howard I. Maibach
Abstract
Peter Elsner, Howard I. Maibach
Abstract
European Union 617 USA 618 Advances in the Science of Skin and Cosmetic Care 619 References 622 Before discussing the need for creating or managing a room for a category of in-between products which cannot enter either within cosmetics or within the scope of drugs, it seems reasonable as a first approach to give consideration to the present frame and scope of cosmetics vs. drugs.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
European Union 617 USA 618 Advances in the Science of Skin and Cosmetic Care 619 References 622 Before discussing the need for creating or managing a room for a category of in-between products which cannot enter either within cosmetics or within the scope of drugs, it seems reasonable as a first approach to give consideration to the present frame and scope of cosmetics vs. drugs.
Key concepts: Cosmeceuticals, Business, Medicine, Cosmetics, Pathology